Polyneuropathy is a condition in which a person’s peripheral nerves are damaged. It affects the nerves in your skin, muscles, and organs. When these nerves are damaged, they can’t send regular signals ...

Polyneuropathy occurs when multiple peripheral nerves become damaged. Symptoms include problems with sensation, coordination, or other body functions. Polyneuropathy is also known as peripheral ...

CIDP causes muscle weakness and numbness, among other symptoms. Diagnosing CIDP involves peripheral nervous system testing, cerebrospinal fluid analysis, and imaging. CIDP is an immune-mediated ...

Polyneuropathy occurs when multiple peripheral nerves malfunction throughout the body. Neuropathy is a common complication of type 2 diabetes mellitus (T2DM). Polyneuropathy occurs when there is ...

Peripheral neuropathy is a general term for nerve damage that causes weakness, numbness and pain, usually in your hands and feet. It can also affect other areas of your body and bodily functions ...

Emerging data suggest a possible genetic contributor to CIDP. In a recent study, patients with CIDP had a high frequency of perforin gene variations that impair the function of cytotoxic T and natural ...

Please provide your email address to receive an email when new articles are posted on . Wainua has received regulatory approval for polyneuropathy of hereditary transthyretin-mediated amyloidosis.

Polyneuropathy, the condition that led to the death of Cincinnati Reds legend Joe Morgan, is a common form of a group of disorders known as peripheral neuropathy. The group of disorders causes damage ...

This page lists all known medications that could potentially lead to 'Polyneuropathy' as a side effect. It's important to note that mild side effects are quite common with medications. The ...

Please provide your email address to receive an email when new articles are posted on . A CRISPR-Cas9-based therapy reduced transthyretin levels in patients with hereditary amyloidosis and ...

The FDA expanded the indication of efgartigimod alfa and hyaluronidase-qvfc (Vyvgart Hytrulo) Friday to include treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP), ...

A significant proportion of patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and dysautonomia may have potentially treatable underlying autoimmune-associated small-fiber ...